Medicenna Therapeutics (MDNAF) Earnings Date & Reports

Medicenna Therapeutics Corp is a Canada-based immuno-oncology company... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

MDNAF is expected to report earnings to fall 13.62% to -4 cents per share on June 25

Medicenna Therapeutics MDNAF Stock Earnings Reports

Q1'25

Est.

$-0.04

Q4'24

Est.

$-0.05

Q3'24

Beat

by $0.01

Q2'24

Est.

$-0.03

Q1'24

Missed

by $0.01

The last earnings report on February 13 showed earnings per share of -4 cents, missing the estimate of -4 cents. With 37.28K shares outstanding, the current market capitalization sits at 54.17M.

View a ticker or compare two or three

Compare

MDNAF

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For MDNAF
(Try 14 days for Free)

Ad is loading...

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

2 Bloor Street W.

Phone

+1 416 648-5555

Employees

Web

https://www.medicenna.com